Comparative risk of infections among JAK inhibitors used in rheumatoid arthritis: A network meta-analysis of clinical trials

被引：0
|
作者：
Alves, Carlos [1 ,2 ]
Mendes, Diogo [2 ]
Penedones, Ana [1 ,2 ]
Marques, Francisco Batel [1 ,2 ]
机构：
[1] Univ Coimbra, Sch Pharm, Coimbra, Portugal
[2] AIBILI Assoc Innovat & Biomed Res Light & Image, Coimbra, Portugal
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
4461
引用
收藏
页码：130 / 130
页数：1
相关论文
共 50 条
  • [31] Infections and serious infections as risks of rituximab in rheumatoid arthritis. Results from an updated meta-analysis of randomised clinical trials
    Velez-Nandayapa, L.
    DeVore, L.
    Parikh, C.
    DRUG SAFETY, 2017, 40 (10) : 990 - 991
  • [32] Clinical Efficacy of Acupuncture for the Treatment of Rheumatoid Arthritis: Meta-Analysis of Randomized Clinical Trials
    Li, Hongchao
    Man, Siliang
    Zhang, Liang
    Hu, Lidong
    Song, Hui
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2022, 2022
  • [33] Comparative efficacy and safety of JAK inhibitors as monotherapy and in combination with methotrexate in patients with active rheumatoid arthritis: A systematic review and meta-analysis
    Liu, Li
    Yan, Yi-Dan
    Shi, Fang-Hong
    Lin, Hou-Wen
    Gu, Zhi-Chun
    Li, Jia
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [34] JAK inhibitors and psoriatic arthritis: A systematic review and meta-analysis
    Campanaro, Francesco
    Batticciotto, Alberto
    Zaffaroni, Andrea
    Cappelli, Antonella
    Donadini, Marco Paolo
    Squizzato, Alessandro
    AUTOIMMUNITY REVIEWS, 2021, 20 (10)
  • [35] JAK INHIBITORS AND PSORIATIC ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Campanaro, F.
    Zaffaroni, A.
    Batticciotto, A.
    Cappelli, A.
    Donadini, M. P.
    Squizzato, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1319 - 1320
  • [36] Infection risk with JAK inhibitors in dermatoses: a meta-analysis
    Ireland, Patrick A.
    Verheyden, Matthew
    Jansson, Nicholas
    Sebaratnam, Deshan
    Sullivan, John
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2025, 64 (01) : 24 - 36
  • [37] Venous Thromboembolism Risk With JAK Inhibitors: A Meta-Analysis
    Yates, Mark
    Mootoo, Amanda
    Adas, Maryam
    Bechman, Katie
    Rampes, Sanketh
    Patel, Vishit
    Qureshi, Sumera
    Cope, Andrew P.
    Norton, Sam
    Galloway, James B.
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 779 - 788
  • [38] Malignancies and Serious Infections in Randomized Controlled Trials of Janus Kinase Inhibitors in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Lopez-Olivo, Maria A.
    Tayar, Jean
    Zamora, Natalia
    Pratt, Gregory
    Suarez-Almazor, Maria
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [39] MALIGNANCIES AND SERIOUS INFECTIONS IN RANDOMISED CONTROLLED TRIALS OF JANUS KINASE INHIBITORS IN PATIENTS WITH RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Lopez-Olivo, M. A.
    Tayar, J. H.
    Zamora, N. V.
    Pratt, G.
    Suarez-Almazor, M. E.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 66 - 66
  • [40] Meta-Analysis of Malignancies, Serious Infections, and Serious Adverse Events with Tofacitinib or Biologic Treatment in Rheumatoid Arthritis Clinical Trials
    Ahadieh, Sima
    Checchio, Tina
    Tensfeldt, Thomas
    French, Jonathan
    Geier, Jamie
    Riese, Richard
    Menon, Sujatha
    Boy, Mary
    Krishnaswami, Sriram
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 : S93 - S94
12345